[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100326281":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":29,"centralContacts":33,"locations":39,"responsibleParty":61,"collaborators":24,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":24,"enrollmentInfo":72,"targetDuration":24,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":83,"overallStatus":42,"whyStopped":24,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"University Hospital, Toulouse","OTHER",[8,13],{"label":9,"type":6,"description":10,"interventionNames":11},"Automated oxygen therapy","An automated oxygen therapy is a system that allows administration of oxygen with a flow that is automatically adjusted to the patient's saturation, which is continuously monitored. Patients will receive O2 automated intervention.",[12],"Device: O2 automated",{"label":14,"type":6,"description":15,"interventionNames":16},"Standard Oxygen therapy","Patients will receive O2 standard therapy",[17],"Device: O2 standard",[19,25],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DEVICE","O2 automated","In the \"O2 automated\" group, patients benefit from oxygen therapy via the \"FreeO2\" device. The O2 saturation target is set by the clinician on the device. Saturation is continuously sensed by an oximeter and the oxygen flow is automatically adjusted. The clinician has access to instantaneous values and trends of O2 and SpO2 flow rates.",[9],null,{"type":20,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"O2 standard","In the \"O2 standard\" group, patients benefit from oxygen therapy with nasal goggles or a high concentration mask. Saturation is continuously captured by an oximeter. The flow rate of oxygen, evaluated in L\u002Fmin, is adapted according to local protocols (every 8 hours in conventional hospital services, continuous in intensive care",[14],[30],{"name":31,"affiliation":5,"role":32},"Elise Noel-Savina, MD","PRINCIPAL_INVESTIGATOR",[34],{"name":31,"role":35,"phone":36,"phoneExt":37,"email":38},"CONTACT","5 67 77 16 90","33","noel-savina.e@chu-toulouse.fr",[40],{"facility":41,"status":42,"city":43,"state":24,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"CHU Larrey","RECRUITING","Toulouse","31049","France","FR",{"type":48,"coordinates":49},"Point",[50,51],1.44367,43.60426,{"lat":51,"lon":50},[54,55,56,59],{"name":31,"role":35,"phone":36,"phoneExt":37,"email":38},{"name":31,"role":32,"phone":24,"phoneExt":24,"email":24},{"name":57,"role":58,"phone":24,"phoneExt":24,"email":24},"Sandrine Pontier-Marchandise, MD","SUB_INVESTIGATOR",{"name":60,"role":58,"phone":24,"phoneExt":24,"email":24},"Alain Didier, MD",{"type":62,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100326281","automated-oxygen-administration-in-patients-with-hypoxemic-pneumonia-and-pleuropneumonia-100326281",false,"NCT03527992","Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia","OPPAÎ","Inclusion Criteria:\n\n* Adult\n* Patient living at home or in an institution\n* Patient hospitalized for less than 48 hours\n* Pneumonia defined (according to the 2006 French-speaking infectious pneumology society (SPILF) criteria) by:\n\n  * respiratory functional symptoms (cough, sputum, dyspnea, chest pain) and\n  * Hyperthermia \\>38,5°C or hypothermia \\\u003C36°C and\n  * Radiological Signs of Pneumonia\n* Hypoxia : SpO2 \\\u003C 94% in ambient air and\u002For PaO2\\\u003C 60 mmHg in ambient air\n\nExclusion Criteria:\n\n* Pneumonia acquired at the hospital.\n* Patient hospitalized in another department more than 48 hours before admission\n* Chronic respiratory failure\n* Active neoplasia\n* Patients undergoing oxygen therapy and \u002F or long-term NIV\n* Associated cardiac decompensation (clinical signs and \u002F or NTproBNP\\> 1800ng \u002F mL) (3\n* Initial Need for high flow oxygen therapy or ventilatory support (NIV, VI)\n* Difficulties expected from home support.","ALL","18 Years",{"count":73,"type":74},128,"ESTIMATED","INTERVENTIONAL",[77],"NA","Hypoxemic pneumonia is a major cause of hospitalization in Pulmonology. The patient's dependency on oxygen prevents early discharge from the hospital. An automated oxygen therapy is a system that allows administration of oxygen with a flow that is automatically adjusted to the patient's saturation, which is continuously monitored. This system has proven to be particularly effective with chronic obstructive pulmonary disease (COPD) patients, by decreasing the time spent in hypoxia and hyperoxia, and by accelerating the weaning of oxygen. Our hypothesis is that automated oxygen therapy leads to a diminution on the length of hospital stay.",[80,81,82],"Pneumonia","Pneumonia, Ventilator-Associated","Length of Stay",[84,85,9,86,87],"Randomized Therapeutic trial","Hypoxemic pneumonia","Length of stay","medico-economic cost","2024-08-01",{"date":90,"type":91},"2024-08-02","ACTUAL",{"date":93,"type":91},"2018-03-09",{"date":95,"type":74},"2028-10",{"name":5,"class":6},1]